GLOBAL TRANSTHYRETIN AMYLOIDOSIS (ATTR) MARKET 2018 BY MANUFACTURERS, COUNTRIES, TYPE AND APPLICATION, FORECAST TO 2023

Nov 2018 117
Table of Contents

1 Transthyretin Amyloidosis (ATTR) Market Overview
1.1 Product Overview and Scope of Transthyretin Amyloidosis (ATTR)
1.2 Classification of Transthyretin Amyloidosis (ATTR) by Types
1.2.1 Global Transthyretin Amyloidosis (ATTR) Revenue Comparison by Types (2017-2023)
1.2.2 Global Transthyretin Amyloidosis (ATTR) Revenue Market Share by Types in 2017
1.2.3 Hereditary ATTR (HATTR)
1.2.4 Wild-Type (WT) ATTR
1.3 Global Transthyretin Amyloidosis (ATTR) Market by Application
1.3.1 Global Transthyretin Amyloidosis (ATTR) Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Diagnostic Centers
1.4 Global Transthyretin Amyloidosis (ATTR) Market by Regions
1.4.1 Global Transthyretin Amyloidosis (ATTR) Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Transthyretin Amyloidosis (ATTR) Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Transthyretin Amyloidosis (ATTR) Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Transthyretin Amyloidosis (ATTR) Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Transthyretin Amyloidosis (ATTR) Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Transthyretin Amyloidosis (ATTR) Status and Prospect (2013-2023)
1.5 Global Market Size of Transthyretin Amyloidosis (ATTR) (2013-2023)
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Business Overview
2.1.2 Transthyretin Amyloidosis (ATTR) Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Pfizer Transthyretin Amyloidosis (ATTR) Revenue, Gross Margin and Market Share (2016-2017)
2.2 Alnylam Pharmaceuticals
2.2.1 Business Overview
2.2.2 Transthyretin Amyloidosis (ATTR) Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Alnylam Pharmaceuticals Transthyretin Amyloidosis (ATTR) Revenue, Gross Margin and Market Share (2016-2017)
2.3 Ionis Pharmaceuticals
2.3.1 Business Overview
2.3.2 Transthyretin Amyloidosis (ATTR) Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Ionis Pharmaceuticals Transthyretin Amyloidosis (ATTR) Revenue, Gross Margin and Market Share (2016-2017)
2.4 Corino Therapeutics
2.4.1 Business Overview
2.4.2 Transthyretin Amyloidosis (ATTR) Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Corino Therapeutics Transthyretin Amyloidosis (ATTR) Revenue, Gross Margin and Market Share (2016-2017)
2.5 Proclara Bioscience
2.5.1 Business Overview
2.5.2 Transthyretin Amyloidosis (ATTR) Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Proclara Bioscience Transthyretin Amyloidosis (ATTR) Revenue, Gross Margin and Market Share (2016-2017)
2.6 Arcturus Therapeutics
2.6.1 Business Overview
2.6.2 Transthyretin Amyloidosis (ATTR) Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Arcturus Therapeutics Transthyretin Amyloidosis (ATTR) Revenue, Gross Margin and Market Share (2016-2017)
3 Global Transthyretin Amyloidosis (ATTR) Market Competition, by Players
3.1 Global Transthyretin Amyloidosis (ATTR) Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Transthyretin Amyloidosis (ATTR) Players Market Share
3.2.2 Top 10 Transthyretin Amyloidosis (ATTR) Players Market Share
3.3 Market Competition Trend
4 Global Transthyretin Amyloidosis (ATTR) Market Size by Regions
4.1 Global Transthyretin Amyloidosis (ATTR) Revenue and Market Share by Regions
4.2 North America Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)
4.3 Europe Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)
4.5 South America Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)
5 North America Transthyretin Amyloidosis (ATTR) Revenue by Countries
5.1 North America Transthyretin Amyloidosis (ATTR) Revenue by Countries (2013-2018)
5.2 USA Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)
5.3 Canada Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)
5.4 Mexico Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)
6 Europe Transthyretin Amyloidosis (ATTR) Revenue by Countries
6.1 Europe Transthyretin Amyloidosis (ATTR) Revenue by Countries (2013-2018)
6.2 Germany Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)
6.3 UK Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)
6.4 France Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)
6.5 Russia Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)
6.6 Italy Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Transthyretin Amyloidosis (ATTR) Revenue by Countries
7.1 Asia-Pacific Transthyretin Amyloidosis (ATTR) Revenue by Countries (2013-2018)
7.2 China Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)
7.3 Japan Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)
7.4 Korea Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)
7.5 India Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)
8 South America Transthyretin Amyloidosis (ATTR) Revenue by Countries
8.1 South America Transthyretin Amyloidosis (ATTR) Revenue by Countries (2013-2018)
8.2 Brazil Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)
8.3 Argentina Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)
8.4 Colombia Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Transthyretin Amyloidosis (ATTR) by Countries
9.1 Middle East and Africa Transthyretin Amyloidosis (ATTR) Revenue by Countries (2013-2018)
9.2 Saudi Arabia Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)
9.3 UAE Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)
9.4 Egypt Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)
9.5 Nigeria Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)
9.6 South Africa Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)
10 Global Transthyretin Amyloidosis (ATTR) Market Segment by Type
10.1 Global Transthyretin Amyloidosis (ATTR) Revenue and Market Share by Type (2013-2018)
10.2 Global Transthyretin Amyloidosis (ATTR) Market Forecast by Type (2018-2023)
10.3 Hereditary ATTR (HATTR) Revenue Growth Rate (2013-2023)
10.4 Wild-Type (WT) ATTR Revenue Growth Rate (2013-2023)
11 Global Transthyretin Amyloidosis (ATTR) Market Segment by Application
11.1 Global Transthyretin Amyloidosis (ATTR) Revenue Market Share by Application (2013-2018)
11.2 Transthyretin Amyloidosis (ATTR) Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Ambulatory Surgical Centers Revenue Growth (2013-2018)
11.5 Diagnostic Centers Revenue Growth (2013-2018)
12 Global Transthyretin Amyloidosis (ATTR) Market Size Forecast (2018-2023)
12.1 Global Transthyretin Amyloidosis (ATTR) Market Size Forecast (2018-2023)
12.2 Global Transthyretin Amyloidosis (ATTR) Market Forecast by Regions (2018-2023)
12.3 North America Transthyretin Amyloidosis (ATTR) Revenue Market Forecast (2018-2023)
12.4 Europe Transthyretin Amyloidosis (ATTR) Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Transthyretin Amyloidosis (ATTR) Revenue Market Forecast (2018-2023)
12.6 South America Transthyretin Amyloidosis (ATTR) Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Transthyretin Amyloidosis (ATTR) Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Transthyretin Amyloidosis (ATTR) Picture
Table Product Specifications of Transthyretin Amyloidosis (ATTR)
Table Global Transthyretin Amyloidosis (ATTR) and Revenue (Million USD) Market Split by Product Type
Figure Global Transthyretin Amyloidosis (ATTR) Revenue Market Share by Types in 2017
Figure Hereditary ATTR (HATTR) Picture
Figure Wild-Type (WT) ATTR Picture
Table Global Transthyretin Amyloidosis (ATTR) Revenue (Million USD) by Application (2013-2023)
Figure Transthyretin Amyloidosis (ATTR) Revenue Market Share by Applications in 2017
Figure Hospitals Picture
Figure Ambulatory Surgical Centers Picture
Figure Diagnostic Centers Picture
Table Global Market Transthyretin Amyloidosis (ATTR) Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Transthyretin Amyloidosis (ATTR) Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Transthyretin Amyloidosis (ATTR) Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Transthyretin Amyloidosis (ATTR) Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Transthyretin Amyloidosis (ATTR) Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Transthyretin Amyloidosis (ATTR) Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Transthyretin Amyloidosis (ATTR) Revenue (Million USD) and Growth Rate (2013-2023)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Transthyretin Amyloidosis (ATTR) Type and Applications
Table Pfizer Transthyretin Amyloidosis (ATTR) Revenue, Gross Margin and Market Share (2016-2017)
Table Alnylam Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Alnylam Pharmaceuticals Transthyretin Amyloidosis (ATTR) Type and Applications
Table Alnylam Pharmaceuticals Transthyretin Amyloidosis (ATTR) Revenue, Gross Margin and Market Share (2016-2017)
Table Ionis Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Ionis Pharmaceuticals Transthyretin Amyloidosis (ATTR) Type and Applications
Table Ionis Pharmaceuticals Transthyretin Amyloidosis (ATTR) Revenue, Gross Margin and Market Share (2016-2017)
Table Corino Therapeutics Basic Information, Manufacturing Base and Competitors
Table Corino Therapeutics Transthyretin Amyloidosis (ATTR) Type and Applications
Table Corino Therapeutics Transthyretin Amyloidosis (ATTR) Revenue, Gross Margin and Market Share (2016-2017)
Table Proclara Bioscience Basic Information, Manufacturing Base and Competitors
Table Proclara Bioscience Transthyretin Amyloidosis (ATTR) Type and Applications
Table Proclara Bioscience Transthyretin Amyloidosis (ATTR) Revenue, Gross Margin and Market Share (2016-2017)
Table Arcturus Therapeutics Basic Information, Manufacturing Base and Competitors
Table Arcturus Therapeutics Transthyretin Amyloidosis (ATTR) Type and Applications
Table Arcturus Therapeutics Transthyretin Amyloidosis (ATTR) Revenue, Gross Margin and Market Share (2016-2017)
Table Global Transthyretin Amyloidosis (ATTR) Revenue (Million USD) by Players (2013-2018)
Table Global Transthyretin Amyloidosis (ATTR) Revenue Share by Players (2013-2018)
Figure Global Transthyretin Amyloidosis (ATTR) Revenue Share by Players in 2016
Figure Global Transthyretin Amyloidosis (ATTR) Revenue Share by Players in 2017
Figure Global Top 5 Players Transthyretin Amyloidosis (ATTR) Revenue Market Share in 2017
Figure Global Top 10 Players Transthyretin Amyloidosis (ATTR) Revenue Market Share in 2017
Figure Global Transthyretin Amyloidosis (ATTR) Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Transthyretin Amyloidosis (ATTR) Revenue (Million USD) by Regions (2013-2018)
Table Global Transthyretin Amyloidosis (ATTR) Revenue Market Share by Regions (2013-2018)
Figure Global Transthyretin Amyloidosis (ATTR) Revenue Market Share by Regions (2013-2018)
Figure Global Transthyretin Amyloidosis (ATTR) Revenue Market Share by Regions in 2017
Figure North America Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)
Figure Europe Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)
Figure South America Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)
Table North America Transthyretin Amyloidosis (ATTR) Revenue by Countries (2013-2018)
Table North America Transthyretin Amyloidosis (ATTR) Revenue Market Share by Countries (2013-2018)
Figure North America Transthyretin Amyloidosis (ATTR) Revenue Market Share by Countries (2013-2018)
Figure North America Transthyretin Amyloidosis (ATTR) Revenue Market Share by Countries in 2017
Figure USA Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)
Figure Canada Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)
Figure Mexico Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)
Table Europe Transthyretin Amyloidosis (ATTR) Revenue (Million USD) by Countries (2013-2018)
Figure Europe Transthyretin Amyloidosis (ATTR) Revenue Market Share by Countries (2013-2018)
Figure Europe Transthyretin Amyloidosis (ATTR) Revenue Market Share by Countries in 2017
Figure Germany Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)
Figure UK Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)
Figure France Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)
Figure Russia Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)
Figure Italy Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Transthyretin Amyloidosis (ATTR) Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Transthyretin Amyloidosis (ATTR) Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Transthyretin Amyloidosis (ATTR) Revenue Market Share by Countries in 2017
Figure China Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)
Figure Japan Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)
Figure Korea Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)
Figure India Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)
Table South America Transthyretin Amyloidosis (ATTR) Revenue by Countries (2013-2018)
Table South America Transthyretin Amyloidosis (ATTR) Revenue Market Share by Countries (2013-2018)
Figure South America Transthyretin Amyloidosis (ATTR) Revenue Market Share by Countries (2013-2018)
Figure South America Transthyretin Amyloidosis (ATTR) Revenue Market Share by Countries in 2017
Figure Brazil Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)
Figure Argentina Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)
Figure Colombia Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Transthyretin Amyloidosis (ATTR) Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Transthyretin Amyloidosis (ATTR) Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Transthyretin Amyloidosis (ATTR) Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Transthyretin Amyloidosis (ATTR) Revenue Market Share by Countries in 2017
Figure Saudi Arabia Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)
Figure UAE Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)
Figure Egypt Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)
Figure Nigeria Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)
Figure South Africa Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)
Table Global Transthyretin Amyloidosis (ATTR) Revenue (Million USD) by Type (2013-2018)
Table Global Transthyretin Amyloidosis (ATTR) Revenue Share by Type (2013-2018)
Figure Global Transthyretin Amyloidosis (ATTR) Revenue Share by Type (2013-2018)
Figure Global Transthyretin Amyloidosis (ATTR) Revenue Share by Type in 2017
Table Global Transthyretin Amyloidosis (ATTR) Revenue Forecast by Type (2018-2023)
Figure Global Transthyretin Amyloidosis (ATTR) Market Share Forecast by Type (2018-2023)
Figure Global Hereditary ATTR (HATTR) Revenue Growth Rate (2013-2018)
Figure Global Wild-Type (WT) ATTR Revenue Growth Rate (2013-2018)
Table Global Transthyretin Amyloidosis (ATTR) Revenue by Application (2013-2018)
Table Global Transthyretin Amyloidosis (ATTR) Revenue Share by Application (2013-2018)
Figure Global Transthyretin Amyloidosis (ATTR) Revenue Share by Application (2013-2018)
Figure Global Transthyretin Amyloidosis (ATTR) Revenue Share by Application in 2017
Table Global Transthyretin Amyloidosis (ATTR) Revenue Forecast by Application (2018-2023)
Figure Global Transthyretin Amyloidosis (ATTR) Market Share Forecast by Application (2018-2023)
Figure Global Hospitals Revenue Growth Rate (2013-2018)
Figure Global Ambulatory Surgical Centers Revenue Growth Rate (2013-2018)
Figure Global Diagnostic Centers Revenue Growth Rate (2013-2018)
Figure Global Transthyretin Amyloidosis (ATTR) Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Transthyretin Amyloidosis (ATTR) Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Transthyretin Amyloidosis (ATTR) Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Transthyretin Amyloidosis (ATTR) Revenue Market Forecast (2018-2023)
Figure Europe Transthyretin Amyloidosis (ATTR) Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Transthyretin Amyloidosis (ATTR) Revenue Market Forecast (2018-2023)
Figure South America Transthyretin Amyloidosis (ATTR) Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Transthyretin Amyloidosis (ATTR) Revenue Market Forecast (2018-2023)

Table of Contents

Related reports :

(Nov 18)

Rosacea is a long-term skin condition that typically affects the face. Scope of the Report: Therapy for the treatment ...

(Nov 18)

Surgical services are conducted by highly skilled surgeons with vast experience in veterinary medicine and animal science and range from sim...

(Nov 18)

Facial paralysis is a restriction of the facial movement due to nerve damage. Facial nerve paralysis is characterized by unilateral facial w...

(Nov 18)

A urethral stricture is a narrowing of the urethra caused by injury, instrumentation, infection and certain non-infectious forms of urethrit...

(Nov 18)

Osteomyelitis (OM) is an infection of bone. Symptoms may include pain in a specific bone with overlying redness, fever, and weakness. The lo...

(Nov 18)

Rumination syndrome, or Merycism, is an under-diagnosed chronic motility disorder characterized by effortless regurgitation of most meals fo...


GLOBAL TRANSTHYRETIN AMYLOIDOSIS (ATTR) MARKET 2018 BY MANUFACTURERS, COUNTRIES, TYPE AND APPLICATION, FORECAST TO 2023

Share this report on:

Subscription Option


Using our subscription option, you get access to Market Research Reports and industry data of Medical Devices market as per your needs. Get the best of Medical Devices research reports by utilizing your research budgets in an optimum way. Contact for details

Contact for reports

*

We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy